Skip to main content
Premium Trial:

Request an Annual Quote

Ontario Children’s Hospital Using BioTrove's OpenArray in Pathogen Detection Studies

NEW YORK (GenomeWeb News) — The Children’s Hospital of Eastern Ontario will collaborate with BioTrove to evaluate the company’s nanofluidic PCR technology for use in detecting and monitoring respiratory infectious disease pathogens in children.
The collaboration will combine BioTrove’s OpenArray with CHEO’s “clinical and molecular biology expertise for rapid, simultaneous identification and quantification of multiple viral and bacterial respiratory pathogens in a clinical specimen,” the company said.
Robert Slinger, who is a medical microbiologist at CHEO, said in a statement that the collaborators intend to design an “all-inclusive assay to rapidly identify and quantify over thirty infectious respiratory viral and bacterial disease targets, potentially enabling physicians to prescribe the right therapies for their patients almost immediately.”
These targets include viral agents such as influenza and emerging pathogens such as MRSA.
BioTrove Chief Technology Officer Colin Brenan said in a statement that the collaborative research could “lead to additional applications for the OpenArray platform, and speaks to the viability and potential of this research system as an applied tool in the clinical laboratory setting.”
Financial terms of the agreement were not released.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.